BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Subramani E, Radoul M, Najac C, Batsios G, Molloy AR, Hong D, Gillespie AM, Santos RD, Viswanath P, Costello JF, Pieper RO, Ronen SM. Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment. Cancer Res 2020;80:5098-108. [PMID: 32958546 DOI: 10.1158/0008-5472.CAN-20-1314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Radoul M, Hong D, Gillespie AM, Najac C, Viswanath P, Pieper RO, Costello JF, Luchman HA, Ronen SM. Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in Glioma. Metabolites 2021;11:109. [PMID: 33668509 DOI: 10.3390/metabo11020109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Padelli F, Mazzi F, Erbetta A, Chiapparini L, Doniselli FM, Palermo S, Aquino D, Bruzzone MG, Cuccarini V. In vivo brain MR spectroscopy in gliomas: clinical and pre-clinical chances. Clin Transl Imaging. [DOI: 10.1007/s40336-022-00502-y] [Reference Citation Analysis]
3 Batsios G, Taglang C, Cao P, Gillespie AM, Najac C, Subramani E, Wilson DM, Flavell RR, Larson PEZ, Ronen SM, Viswanath P. Imaging 6-Phosphogluconolactonase Activity in Brain Tumors In Vivo Using Hyperpolarized δ-[1-13C]gluconolactone. Front Oncol 2021;11:589570. [PMID: 33937017 DOI: 10.3389/fonc.2021.589570] [Reference Citation Analysis]
4 Cha JW, Jin X, Jo S, An YJ, Park S. Metabolic mechanisms of a drug revealed by distortion-free 13C tracer analysis. Chem Sci 2021;12:4958-62. [PMID: 34168765 DOI: 10.1039/d0sc06480g] [Reference Citation Analysis]
5 Sun X, Turcan S. From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas. Cells 2021;10:1225. [PMID: 34067729 DOI: 10.3390/cells10051225] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wei RL, Wei XT. Advanced Diagnosis of Glioma by Using Emerging Magnetic Resonance Sequences. Front Oncol 2021;11:694498. [PMID: 34422648 DOI: 10.3389/fonc.2021.694498] [Reference Citation Analysis]
7 Kumar M, Nanga RPR, Verma G, Wilson N, Brisset JC, Nath K, Chawla S. Emerging MR Imaging and Spectroscopic Methods to Study Brain Tumor Metabolism. Front Neurol 2022;13:789355. [DOI: 10.3389/fneur.2022.789355] [Reference Citation Analysis]
8 Gatto L, Franceschi E, Tosoni A, Di Nunno V, Maggio I, Lodi R, Brandes AA. IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment. Mol Diagn Ther 2021;25:457-73. [PMID: 34095989 DOI: 10.1007/s40291-021-00537-3] [Reference Citation Analysis]